Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Rationale for phase I study of UFT plus leucovorin and oral JM-216.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rationale for phase I study of UFT plus leucovorin and oral JM-216.
Rationale for phase I study of UFT plus leucovorin and oral JM-216. Oncology (Williston Park). 1997 Sep; 11(9 Suppl 10):26-9.
View in:
PubMed
subject areas
Administration, Oral
Antidotes
Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Drug Combinations
Drug Therapy, Combination
Humans
Leucovorin
Organoplatinum Compounds
Tegafur
Uracil
authors with profiles
Mark J. Ratain